🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Capsule(s) Serving Size
60 Servings
Non-Nutrient/Non-Botanical Product Type
0% Evidence Coverage

Supplement Facts — Evidence Check

Astragalosides
250 mg

Other Ingredients

Cellulose Microcrystalline Cellulose Leucine

Label Claims — Verification

All Other
Structure/Function

Target Groups

Vegetarian Adult (18 - 50 Years) Women (not pregnant or lactating) Gluten Free

Product Information

📋 Directions for Use

Suggested use: As a dietary supplement, adults take 1 capsule once or twice daily, or as directed by your healthcare practitioner.

⚠️ Warnings & Precautions

Warning: If pregnant, nursing, or planning to become pregnant do not take this product.

Caution: If you have an autoimmune disease or if you are taking immuno-suppressants, consult with your healthcare practitioner before taking this product.

Keep out of reach of children.

To obtain product information or report a serious adverse event, call 1-800-325-1776.

🧪 Formulation Notes

Color of this product may vary due to color variations of the natural ingredients.

A dietary supplement to support healthy aging and telomerase activity

Vegetarian/ gluten free/ soy free

Vegetarian/ gluten free/ soy free

Additional Information

The Benefit Line is designed for power. Each formula offers clinically relevant levels of evidence-based nutrients to provide with less.

Store in a cool, dry place.

Product Details

UPC / SKU 0 26664 00331 7
DSLD Entry Date 2023-06-22
Product Type Non-Nutrient/Non-Botanical
Form Capsule
DSLD ID 288110
Data Updated 2026-04-11

Research Evidence

We're building the evidence profile for this product's ingredients.

Our team is working to connect every product on the American market with peer-reviewed research. Check back soon for evidence-backed analysis.